Case File №
#VI-2026-0787
Guangzhou Yuao Trading
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 6.8 | 6.8 | 6.8 | 25 May 2026 |
| AHK-CU | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| AICAR | X N/A | 1 | 4.0 | 2.8 | 2.8 | 6 May 2025 |
| Cartalax | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 0.1 | 0.1 | 24 Apr 2025 |
| DSIP | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Estradiol Cypionate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 0.5 | 0.5 | 8 Jul 2025 |
| KPV | X N/A | 1 | 4.0 | 3.2 | 3.2 | 13 Feb 2025 |
| Methylene Blue | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Metribolone | X N/A | 1 | 4.0 | 2.1 | 2.1 | 24 Apr 2025 |
| NandroMix 300 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Orforglipron | X N/A | 1 | 4.0 | 1.2 | 1.2 | 7 May 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| PEG MGF | X N/A | 1 | 4.0 | 1.9 | 1.9 | 8 Jul 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Prostamax | X N/A | 1 | 4.0 | 0.1 | 0.1 | 7 May 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 0.3 | 0.3 | 28 Mar 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.7 | 0.7 | 2 Apr 2025 |
| Romosozumab | X N/A | 1 | 4.0 | 0.8 | 0.8 | 24 Apr 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 2.3 | 2.3 | 3 Jul 2025 |
| Semaglutide Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | X N/A | 1 | 4.0 | 1.5 | 1.5 | 16 Mar 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 4.0 | 0.4 | 0.4 | 20 Jun 2025 |
| Stanozolol (Winstrol) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Super Shred | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Superdrol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Telmisartan | X N/A | 1 | 4.0 | 1.4 | 1.4 | 3 Jul 2025 |
| Test Base (No Ester) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Thymalin | X N/A | 1 | 4.0 | 0.8 | 0.8 | 8 Jul 2025 |
| Turinabol Raw | X N/A | 1 | 4.0 | 0.5 | 0.5 | 20 Jun 2025 |
Exhibit II
Evidence Log
32 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | PE 22-28 | 5.6 B | 5mg | 5.6mg | +12.3% | 96.40% | bhdue3 | Lab F | Public |
| 24 May 2026 | DSIP | 5.0 B | 15mg | 18.6mg | +24.3% | 96.51% | 5t2r18 | Lab B | Public |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 4.3 C | 15mg | 17.5mg | +16.6% | 97.09% | 5i71rt | Lab F | Community |
| 24 May 2026 | Methylene Blue | 4.0 C | 10mg | 10.4mg | +3.9% | 96.52% | ta8z83 | Lab F | Public |
| 24 May 2026 | Prostamax | 4.3 C | 30mg | 33.8mg | +12.8% | 96.10% | 1uoolb | Lab G | Community |
| 24 May 2026 | Super Shred | 6.3 A | 100mg/ml | 123.4mg/ml | +23.4% | 95.64% | rfbvlf | Lab F | Community |
| 23 May 2026 | Cartalax | 4.5 C | 2mg | 2.2mg | +9.0% | 98.40% | py2etn | Lab D | Community |
| 23 May 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.7 C | 10mg | 9.0mg | -10.0% | 99.40% | az00hi | Lab D | Public |
| 21 May 2026 | GHRP-2 Acetate | 4.0 C | 30mg | 32.1mg | +7.1% | 98.88% | 75loc7 | Lab G | Community |
| 21 May 2026 | Estradiol Cypionate | 6.6 A | 100mg/ml | 110.7mg/ml | +10.7% | 98.78% | bkw2kd | Lab B | Community |
| 21 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.9 C | 200mg/ml | 197.3mg/ml | -1.3% | 96.76% | 04v26w | Lab A | Public |
| 20 May 2026 | AICAR | 4.0 C | 20mg | 19.9mg | -0.7% | 97.95% | y3enbs | Lab D | Public |
| 20 May 2026 | CJC-1295 With DAC | 4.0 C | 15mg | 16.9mg | +12.7% | 96.92% | gjg3gu | Lab C | Public |
| 20 May 2026 | Semaglutide Raw | 4.0 C | 10g | 12.3g | +23.2% | 99.32% | 3xg3d2 | Lab F | Public |
| 17 May 2026 | NandroMix 300 | 4.0 C | 100mg/ml | 113.9mg/ml | +13.9% | 97.44% | cijdbn | Lab B | Public |
| 26 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 4.0 C | 10mg | 12.0mg | +20.1% | 98.99% | 7uppmx | Lab B | Community |
| 19 Jan 2026 | Test Base (No Ester) | 4.0 C | 300mg/ml | 319.2mg/ml | +6.4% | 99.44% | u5sx8y | Lab B | Public |
| 9 Jan 2026 | Metribolone | 6.2 A | 100mg/ml | 111.5mg/ml | +11.5% | 99.51% | j6oepj | Lab A | Community |
| 7 Jan 2026 | Selank 10mg + Semax 10mg Blend | 4.4 C | 20mg | 20.5mg | +2.5% | 98.73% | gb56mh | Lab B | Public |
| 7 Jan 2026 | Stanozolol (Winstrol) Raw | 4.1 C | 100g | 106.5g | +6.5% | 98.06% | n4ahp8 | Lab C | Public |
| 7 Jan 2026 | Superdrol | 4.0 C | 25mg | 21.3mg | -14.7% | 95.87% | qckybc | Lab E | Public |
| 5 Dec 2025 | Thymalin | 4.2 C | 50mg | 51.3mg | +2.5% | 95.70% | jj8d15 | Lab G | Public |
| 23 Nov 2025 | PTD-DBM | 5.2 B | 20mg | 24.2mg | +20.8% | 96.75% | zqyvwt | Lab C | Community |
| 17 Nov 2025 | Orforglipron | 4.0 C | 100mg | 99.2mg | -0.8% | 99.37% | xrvc4t | Lab G | Public |
| 17 Nov 2025 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 4.0 C | 250mg/ml | 309.4mg/ml | +23.8% | 96.15% | q60qjh | Lab D | Public |
| 17 Nov 2025 | Turinabol Raw | 6.4 A | 1g | 1.1g | +10.9% | 95.42% | ni3ufk | Lab B | Public |
| 14 Nov 2025 | KPV | 6.2 A | 30mg | 30.5mg | +1.5% | 97.20% | 7cgnhz | Lab A | Public |
| 14 Nov 2025 | PEG MGF | 4.0 C | 50mg | 61.5mg | +23.1% | 96.26% | y6j7bo | Lab E | Public |
| 5 Nov 2025 | AHK-CU | 4.0 C | 15mg | 13.6mg | -9.1% | 95.12% | oh82po | Lab C | Community |
| 5 Nov 2025 | Telmisartan | 4.0 C | 25mg | 22.0mg | -11.9% | 97.16% | rl7dhx | Lab E | Public |
| 17 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.7 A | 30mg | 30.7mg | +2.4% | 98.98% | zt32rm | Lab D | Public |
| 17 Oct 2025 | Romosozumab | 4.0 C | 50mg | 50.8mg | +1.6% | 97.40% | ecy53l | Lab E | Public |
— END OF EVIDENCE LOG —